NASDAQ · Healthcare · Biotechnology
OKYO Pharma Limited
OKYO
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. CEO Robert J. Dempsey · Market cap $57.7M.
$1.50
-0.01 · -0.99%
52w hi $3.2052w lo $1.34
Off 52w high 55.3%
70
NOTABLE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $5.00
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 21 | Flavio Mantelli | CHIEF MEDICAL OFFICER | Buy | 20,000 | $1.40 | +$28K | 70 |
| Jul 21 | Gabriele M Cerrone | Buy | 22,500 | $1.45 | +$33K | 59 | |
| Jul 20 | Gabriele M Cerrone | Buy | 25,000 | $1.40 | +$35K | 59 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug